Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer

Marco Ranzani1, Daniela Cesana, Cynthia C Bartholomae

  • 1San Raffaele-Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.

Nature Methods
|January 15, 2013
PubMed

Insights

Researchers developed a lentiviral vector (LVV) platform for insertional mutagenesis, successfully identifying four novel liver cancer genes. This method overcomes limitations of older systems, aiding early cancer driver event discovery in hepatocellular carcinoma (HCC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Insertional mutagenesis using transposons and γ-retroviruses aids cancer gene discovery.
  • Recurring integrations in tumor cells complicate the identification of early cancer drivers.
  • Existing methods struggle to differentiate early events from bystander or progression-related mutations.

Purpose of the Study:

  • To develop a novel insertional mutagenesis platform using lentiviral vectors (LVVs).
  • To efficiently induce hepatocellular carcinoma (HCC) in mouse models.
  • To identify previously unknown liver cancer-associated genes and validate their oncogenic potential.

Main Methods:

  • Developed a lentiviral vector (LVV)-based insertional mutagenesis platform.
  • Induced hepatocellular carcinoma (HCC) in three distinct mouse models.
  • Analyzed integration patterns and validated identified genes in vivo and in human HCC data.

Main Results:

  • The LVV platform efficiently induced HCC across three mouse models.
  • Identified four novel genes associated with liver cancer from a limited number of integrations.
  • Validated the oncogenic potential of these genes in vivo, showing varying penetrance.
  • Confirmed relevance to human HCC, with identified genes showing altered expression, amplification, or deletion, and predicting patient outcomes.

Conclusions:

  • LVV-based insertional mutagenesis is a powerful tool for identifying early cancer drivers.
  • The identified genes represent novel contributors to liver cancer pathogenesis.
  • These findings have implications for understanding and potentially treating human hepatocellular carcinoma.